FDA Inspection 754840 — Servy Institute For Reproductive Endocrinology
The FDA completed an inspection of Servy Institute For Reproductive Endocrinology on Nov 18, 2011 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 18, 2011
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Augusta, GA (United States)